98%
921
2 minutes
20
Introduction: In Positron Emission Tomography (PET) imaging, the use of tracers increases radioactive exposure for longitudinal evaluations and in radiosensitive populations such as pediatrics. However, reducing injected PET activity potentially leads to an unfavorable compromise between radiation exposure and image quality, causing lower signal-to-noise ratios and degraded images. Deep learning-based denoising approaches can be employed to recover low count PET image signals: nonetheless, most of these methods rely on structural or anatomic guidance from magnetic resonance imaging (MRI) and fails to effectively preserve global spatial features in denoised PET images, without impacting signal-to-noise ratios.
Methods: In this study, we developed a novel PET only deep learning framework, the Self-SiMilARiTy-Aware Generative Adversarial Framework (SMART), which leverages Generative Adversarial Networks (GANs) and a self-similarity-aware attention mechanism for denoising [18F]-fluorodeoxyglucose (18F-FDG) PET images. This study employs a combination of prospective and retrospective datasets in its design. In total, 114 subjects were included in the study, comprising 34 patients who underwent 18F-Fluorodeoxyglucose PET (FDG) PET imaging for drug-resistant epilepsy, 10 patients for frontotemporal dementia indications, and 70 healthy volunteers. To effectively denoise PET images without anatomical details from MRI, a self-similarity attention mechanism (SSAB) was devised. which learned the distinctive structural and pathological features. These SSAB-enhanced features were subsequently applied to the SMART GAN algorithm and trained to denoise the low-count PET images using the standard dose PET image acquired from each individual participant as reference. The trained GAN algorithm was evaluated using image quality measures including structural similarity index measure (SSIM), peak signal-to-noise ratio (PSNR), normalized root mean square (NRMSE), Fréchet inception distance (FID), signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR).
Results: In comparison to the standard-dose, SMART-PET had on average a SSIM of 0.984 ± 0.007, PSNR of 38.126 ± 2.631 dB, NRMSE of 0.091 ± 0.028, FID of 0.455 ± 0.065, SNR of 0.002 ± 0.001, and CNR of 0.011 ± 0.011. Regions of interest measurements obtained with datasets decimated down to 10% of the original counts, showed a deviation of less than 1.4% when compared to the ground-truth values.
Discussion: In general, SMART-PET shows promise in reducing noise in PET images and can synthesize diagnostic quality images with a 90% reduction in standard of care injected activity. These results make it a potential candidate for clinical applications in radiosensitive populations and for longitudinal neurological studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11611550 | PMC |
http://dx.doi.org/10.3389/fnume.2024.1469490 | DOI Listing |
Mol Pharm
September 2025
Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Tissue factor (TF) has emerged as a promising target for the diagnosis and treatment of hepatocellular carcinoma (HCC). However, there is limited data available on TF-related PET imaging for longitudinal monitoring of the pathophysiological changes during HCC formation. Herein, we aimed to explore the TF-expression feature and compare a novel TF-targeted PET probe with F-FDG through longitudinal imaging in diethylnitrosamine (DEN)-induced rat HCC.
View Article and Find Full Text PDFJ Pediatr Hematol Oncol
September 2025
Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
Purpose: In children with Langerhans Cell Histiocytosis (LCH), FDG-PET/CT is used for staging and response assessment. Whole-body MRI (WB-MRI) can serve as an ionizing radiation-free alternative for repeated whole-body imaging. The aim of this study was to compare WB-MRI with FDG-PET/CT for staging and response assessment in pediatric LCH.
View Article and Find Full Text PDFJAMA Netw Open
September 2025
School of Medicine and Public Health, University of Wisconsin-Madison, Madison.
Importance: It is unclear whether the duration of amyloid-β (Aβ) pathology is associated with neurodegeneration and whether this depends on the presence of tau.
Objective: To examine the association of longitudinal atrophy with Aβ positron emission tomography (PET)-positivity (Aβ+) and the estimated duration of Aβ+ (Aβ+ duration), controlling for tau-positivity.
Design, Setting, And Participants: Data for this longitudinal cohort study were drawn from the Wisconsin Registry for Alzheimer Prevention and the Wisconsin Alzheimer Disease Research Center Clinical Core Study.
Eur J Nucl Med Mol Imaging
September 2025
Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Objective: CXCR4 and integrin αβ play important roles in tumor biology and are highly expressed in multiple types of tumors. This study aimed to synthesize, preclinically evaluate, and clinically validate a novel dual-targeted PET imaging probe Ga-pentixafor-c(RGDfK) for its potential in imaging tumors.
Methods: The effects of Ga-pentixafor-c(RGDfK) on cell viability, targeting specificity, and affinity were assessed in the U87MG cells.
Eur J Nucl Med Mol Imaging
September 2025
Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Purpose: Cardiac noradrenergic denervation visualized by meta-[I]iodobenzylguanidine ([I]MIBG) imaging supports the diagnosis of Parkinson's disease (PD). Recently, meta-[F] fluorobenzylguanidine ([F]MFBG) PET demonstrated favorable imaging characteristics compared with [I]MIBG scintigraphy for neuroendocrine tumors. We assessed [F]MFBG dosimetry and myocardial pharmacokinetics in healthy controls and PD patients.
View Article and Find Full Text PDF